0001127602-22-022258.txt : 20220909 0001127602-22-022258.hdr.sgml : 20220909 20220909164802 ACCESSION NUMBER: 0001127602-22-022258 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220907 FILED AS OF DATE: 20220909 DATE AS OF CHANGE: 20220909 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hoffman William CENTRAL INDEX KEY: 0001304099 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39293 FILM NUMBER: 221236651 MAIL ADDRESS: STREET 1: C/O INARI MEDICAL, INC. STREET 2: 9 PARKER, SUITE 100 CITY: IRVINE STATE: CA ZIP: 92618 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Inari Medical, Inc. CENTRAL INDEX KEY: 0001531048 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 452902923 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6001 OAK CANYON, SUITE 100 CITY: IRVINE STATE: CA ZIP: 92618 BUSINESS PHONE: 949-923-4747 MAIL ADDRESS: STREET 1: 6001 OAK CANYON, SUITE 100 CITY: IRVINE STATE: CA ZIP: 92618 FORMER COMPANY: FORMER CONFORMED NAME: Inceptus Newco1 Inc. DATE OF NAME CHANGE: 20110923 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2022-09-07 0001531048 Inari Medical, Inc. NARI 0001304099 Hoffman William C/O INARI MEDICAL, INC. 6001 OAK CANYON IRVINE CA 92618 1 1 President and CEO Common Stock 2022-08-29 5 G 0 E 139998 0 D 378901 D Common Stock 2022-09-07 4 M 0 30000 .4284 A 408901 D Common Stock 2022-09-07 4 S 0 4646 69.73 D 404255 D Common Stock 2022-09-07 4 S 0 6066 70.94 D 398189 D Common Stock 2022-09-07 4 S 0 14062 71.89 D 384127 D Common Stock 2022-09-07 4 S 0 5226 72.42 D 378901 D Common Stock 2022-09-08 4 S 0 16308 75.12 D 362593 D Stock Option .4284 2022-09-07 4 M 0 30000 0 D 2028-12-13 Common Stock 30000 230168 D The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 16, 2021. This transaction was executed in multiple trades at prices ranging from $69.26 to $70.23. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $70.29 to $71.27. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $71.29 to $72.28. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $72.29 to $72.61 The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $75.00 to $75.36. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. The option is vested and exercisable as to 133,231 shares, and the remaining shares will vest and become exercisable in equal monthly installments until December 13, 2022. /s/ Angela Ahmad, attorney-in-fact for William Hoffman 2022-09-09